About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
PROGRESS
PATIENTS
Enabling a better future for people with rare immune disorders
learn more
now approved in the U.S.!
Learn More
recent news
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2024
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2024
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
August 28, 2024
More News
© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics
